Parkman Healthcare Partners LLC Abb Vie Inc. Transaction History

Parkman Healthcare Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $6.29 Million - $8 Million	-45,731 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $790,692 - $981,026	-5,991 Reduced 11.58%	45,731 $7.41 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $2.5 Million - $3.16 Million	-23,278 Reduced 31.04%	51,722 $7 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $7.98 Million - $9.06 Million	75,000 New	75,000 $8.09 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $3.07 Million - $3.38 Million	-30,000 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $3.62 Million - $4.89 Million	-45,008 Reduced 60.0%	30,000 $3.22 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $687 - $806	8 Added 0.01%	75,008 $6.57 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $5.5 Million - $7.36 Million	75,000 New	75,000 $7.36 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.